NCT06860750

A Trial of SHR-1314 Injection in Adult Patients With Active Non-radiographic Axial Spondyloarthritis

A Randomized, Double-blind, Multicenter, Placebo-controlled Phase III Clinical Study to Evaluate the Efficacy and Safety of SHR-1314 Injection in Adult Patients With Active Non-radiographic Axial Spondyloarthritis

• Status: Recruiting
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 380 (estimated)
• Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The study is being conducted to evaluate the efficacy and safety of SHR-1314 injection in adult patients with active non-radiographic axial spondyloarthritis.

Conditions

• Active Non-radiographic Axial Spondyloarthritis

Interventions

Type	Name	Description
DRUG	SHR-1314 Injection	SHR-1314 injection.
DRUG	SHR-1314 Placebo Injection	SHR-1314 placebo injection.

Timeline

• Start date: 2025-04-29
• Primary completion: 2028-02-01
• Completion: 2028-12-01
• First posted: 2025-03-06
• Last updated: 2025-06-22

Locations

1 site across 1 country: China